Roles of Ki67 in Breast Cancer - Important for Management?
Background: The three standard biomarkers used in breast cancer are the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). The Ki-67 index, a proliferative marker, has been shown to be associated with a poorer outcome, and despite absence of stand...
Main Authors: | Yip, C.H., Bhoo-Pathy, N., Daniel, J.M., Foo, Y.C., Mohamed, A.K., Abdullah, M.M., Ng, Y.S., Yap, B.K., Pathmanathan, R. |
---|---|
Format: | Article |
Published: |
West Asia Organization for Cancer Prevention
2016
|
Subjects: |
Similar Items
-
Assessment Of Proliferation Rate In Breast Cancer By Ki-67 Labeling Index
by: Hussin Khan, Ibrahim
Published: (2017) -
Ki67 and p53 expression in relation to clinicopathological features in phyllodes tumour of the breast
by: Ali, Nurul Atiah Mohd
Published: (2020) -
The pattern of Ki-67 and bcl-2 expression in Lymphoid Malignancies
by: Wang, P.L., et al.
Published: (1997) -
Advanced Stage at Presentation Remains a Major Factor Contributing to Breast Cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country
by: Kong, Y.C., et al.
Published: (2017) -
Expression of p53, pRb, Ki-67 and bcl-2 in betel quid induced oral mucosal lesions
by: Kipli, N.P., et al.
Published: (2005)